Found 26 Enz. Inhib. hit(s) with all data for entry = 8185 
Affinity DataIC50: 0.670nMAssay Description:Compounds of the present invention were evaluated using the human H3 receptor (H3R) HTRF cAMP assay. In this assay, HEK293 cells expressing the human...More data for this Ligand-Target Pair
Affinity DataIC50: 0.780nMAssay Description:Compounds of the present invention were evaluated using the human H3 receptor (H3R) HTRF cAMP assay. In this assay, HEK293 cells expressing the human...More data for this Ligand-Target Pair
Affinity DataIC50: 0.790nMAssay Description:Compounds of the present invention were evaluated using the human H3 receptor (H3R) HTRF cAMP assay. In this assay, HEK293 cells expressing the human...More data for this Ligand-Target Pair
Affinity DataIC50: 0.930nMAssay Description:Compounds of the present invention were evaluated using the human H3 receptor (H3R) HTRF cAMP assay. In this assay, HEK293 cells expressing the human...More data for this Ligand-Target Pair
Affinity DataIC50: 0.950nMAssay Description:Compounds of the present invention were evaluated using the human H3 receptor (H3R) HTRF cAMP assay. In this assay, HEK293 cells expressing the human...More data for this Ligand-Target Pair
Affinity DataIC50: 0.960nMAssay Description:Compounds of the present invention were evaluated using the human H3 receptor (H3R) HTRF cAMP assay. In this assay, HEK293 cells expressing the human...More data for this Ligand-Target Pair
Affinity DataIC50: 0.970nMAssay Description:Compounds of the present invention were evaluated using the human H3 receptor (H3R) HTRF cAMP assay. In this assay, HEK293 cells expressing the human...More data for this Ligand-Target Pair
Affinity DataIC50: 0.990nMAssay Description:Compounds of the present invention were evaluated using the human H3 receptor (H3R) HTRF cAMP assay. In this assay, HEK293 cells expressing the human...More data for this Ligand-Target Pair
Affinity DataIC50: 1.10nMAssay Description:Compounds of the present invention were evaluated using the human H3 receptor (H3R) HTRF cAMP assay. In this assay, HEK293 cells expressing the human...More data for this Ligand-Target Pair
Affinity DataIC50: 1.20nMAssay Description:Compounds of the present invention were evaluated using the human H3 receptor (H3R) HTRF cAMP assay. In this assay, HEK293 cells expressing the human...More data for this Ligand-Target Pair
Affinity DataIC50: 1.20nMAssay Description:Compounds of the present invention were evaluated using the human H3 receptor (H3R) HTRF cAMP assay. In this assay, HEK293 cells expressing the human...More data for this Ligand-Target Pair
Affinity DataIC50: 1.5nMAssay Description:Compounds of the present invention were evaluated using the human H3 receptor (H3R) HTRF cAMP assay. In this assay, HEK293 cells expressing the human...More data for this Ligand-Target Pair
Affinity DataIC50: 1.80nMAssay Description:Compounds of the present invention were evaluated using the human H3 receptor (H3R) HTRF cAMP assay. In this assay, HEK293 cells expressing the human...More data for this Ligand-Target Pair
Affinity DataIC50: 1.90nMAssay Description:Compounds of the present invention were evaluated using the human H3 receptor (H3R) HTRF cAMP assay. In this assay, HEK293 cells expressing the human...More data for this Ligand-Target Pair
Affinity DataIC50: 2.10nMAssay Description:Compounds of the present invention were evaluated using the human H3 receptor (H3R) HTRF cAMP assay. In this assay, HEK293 cells expressing the human...More data for this Ligand-Target Pair
Affinity DataIC50: 2.10nMAssay Description:Compounds of the present invention were evaluated using the human H3 receptor (H3R) HTRF cAMP assay. In this assay, HEK293 cells expressing the human...More data for this Ligand-Target Pair
Affinity DataIC50: 2.5nMAssay Description:Compounds of the present invention were evaluated using the human H3 receptor (H3R) HTRF cAMP assay. In this assay, HEK293 cells expressing the human...More data for this Ligand-Target Pair
Affinity DataIC50: 2.5nMAssay Description:Compounds of the present invention were evaluated using the human H3 receptor (H3R) HTRF cAMP assay. In this assay, HEK293 cells expressing the human...More data for this Ligand-Target Pair
Affinity DataIC50: 3nMAssay Description:Compounds of the present invention were evaluated using the human H3 receptor (H3R) HTRF cAMP assay. In this assay, HEK293 cells expressing the human...More data for this Ligand-Target Pair
Affinity DataIC50: 3.10nMAssay Description:Compounds of the present invention were evaluated using the human H3 receptor (H3R) HTRF cAMP assay. In this assay, HEK293 cells expressing the human...More data for this Ligand-Target Pair
Affinity DataIC50: 3.30nMAssay Description:Compounds of the present invention were evaluated using the human H3 receptor (H3R) HTRF cAMP assay. In this assay, HEK293 cells expressing the human...More data for this Ligand-Target Pair
Affinity DataIC50: 3.80nMAssay Description:Compounds of the present invention were evaluated using the human H3 receptor (H3R) HTRF cAMP assay. In this assay, HEK293 cells expressing the human...More data for this Ligand-Target Pair
Affinity DataIC50: 3.80nMAssay Description:Compounds of the present invention were evaluated using the human H3 receptor (H3R) HTRF cAMP assay. In this assay, HEK293 cells expressing the human...More data for this Ligand-Target Pair
Affinity DataIC50: 5.5nMAssay Description:Compounds of the present invention were evaluated using the human H3 receptor (H3R) HTRF cAMP assay. In this assay, HEK293 cells expressing the human...More data for this Ligand-Target Pair
Affinity DataIC50: 6.90nMAssay Description:Compounds of the present invention were evaluated using the human H3 receptor (H3R) HTRF cAMP assay. In this assay, HEK293 cells expressing the human...More data for this Ligand-Target Pair
Affinity DataIC50: 8.10nMAssay Description:Compounds of the present invention were evaluated using the human H3 receptor (H3R) HTRF cAMP assay. In this assay, HEK293 cells expressing the human...More data for this Ligand-Target Pair
